Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

MNPR US Equity

Monopar TherapeuticsHealth Care · Pharmaceutical Preparations · CIK 1645469 · FY ends Dec 31
$123.84
+4.79 (+4.02%)
USD · as of 2026-08-19 · marketstack
2 8-K filings · 0 13D · 2 13G
DateEventWhat happened / filerSource
2026-08-1213G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Saturn V Capital Management LPsec.gov ↗
2026-08-1213G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Adage Capital Management, L.P.sec.gov ↗
2026-08-128-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-07-228-K 7.01Regulation FD disclosuresec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-22

Every row is a filed document, checked against its EDGAR index.